Statement of Principles concerning malignant neoplasm of the pancreas (Reasonable Hypothesis) (No. 103 of 2021)

This instrument is a Statement of Principles (SoP) made under subsection 196B(2) of the Veterans' Entitlements Act 1986 (VEA) by the Repatriation Medical Authority (RMA). It replaces SoP No. 73 of 2013 and applies to claims under section 120A of the VEA and section 338 of the Military Rehabilitation and Compensation Act 2004 (MRCA). Its mechanical function is to specify the minimum factors that must exist before it can be said that a reasonable hypothesis has been raised connecting malignant neoplasm of the pancreas (pancreatic cancer) or death from that condition with the circumstances of a person's relevant service. The instrument does not create a right to compensation directly; rather it constrains and guides decision-makers in assessing whether the reasonable hypothesis standard of proof is satisfied. If a claimant can establish at least one of the thirteen listed factors, and that factor is related to their relevant service, then a reasonable hypothesis is taken to exist, unless contrary evidence rebuts it. The SoP defines pancreatic cancer narrowly: it covers only primary malignant neoplasms arising from cells of the exocrine pancreas and specifically excludes soft tissue sarcoma, carcinoid tumours, endocrine tumours, non-Hodgkin lymphoma and Hodgkin's lymphoma. The instrument also includes death from a terminal event contributed to by the cancer. The RMA states it is satisfied that there is sound medical-scientific evidence linking the disease to relevant service, but this statement is a claim by the Authority, not a legal finding of fact. The practical effect is that veterans and members with pancreatic cancer who can show exposure to a factor during service (or that the factor itself is service-related) face a lower evidentiary threshold than the balance of probabilities for operational, peacekeeping, hazardous or warlike service. The instrument also incorporates cross-references to other SoPs for conditions such as diabetes or pancreatitis, meaning the chain of causation may require multiple SoPs to be satisfied. This so-called incorporation by reference can increase complexity for claimants and representatives, because a factor may point to an underlying disease that itself must be shown to be service-related through its own SoP. The SoP also implicitly raises the cost of claim determination: each factor demands precise temporal calculations (e.g. 5 years, 10 pack-years, 20 years, 1,000 hours) and medical evidence that the condition or exposure occurred during or resulted from service. The instrument thus defines the boundaries for public compensation liability and directs public expenditure from consolidated revenue.

The central legal concept is the reasonable hypothesis standard, which is lower than the civil standard of proof. Under section 120(1) VEA and section 339 MRCA, if a claim relates to operational, peacekeeping, hazardous or warlike service, the decision-maker must accept a reasonable hypothesis unless it is disproved beyond reasonable doubt. This SoP defines what factors are sufficient to raise that hypothesis for pancreatic cancer. Clinical onset is the point at which the disease becomes clinically apparent and is the temporal reference for many factors. The instrument uses pack-years as a standardised measure of cumulative smoking; one pack-year equals 20 cigarettes per day for a year or an equivalent tobacco weight. This metric penalises heavy cumulative consumption but rewards early cessation, because smoking must have commenced at least five years before onset and if ceased, onset must occur within twenty years. Being overweight or obese is defined using BMI (25 or greater) or waist circumference (above 94 cm for males, above 80 cm for females). The definition reflects a population-based threshold rather than individual risk, and a person may satisfy it through either metric. The exposure factor for DDT requires a cumulative 1,000 hours of inhalation, ingestion or skin contact. The dictionary enumerates specific activities: manufacturing, being sprayed, cleaning equipment, decanting, or handling treated clothes. This is a low-prevalence factor but imposes a high documentary burden , claimants may need to prove hours logged decades ago. Relevant service is defined exclusively as operational, peacekeeping, hazardous or British nuclear test defence service under the VEA, and warlike or non-warlike service under the MRCA. It does not include peacetime service under the VEA (which uses the balance of probabilities standard). The instrument also introduces the concept of inability to obtain appropriate clinical management as factor 13, which applies only to material contribution or aggravation of a pre-existing disease , it does not apply to initial onset. That factor is parasitic on the veteran’s service circumstances preventing proper treatment. Other concepts include smokeless tobacco (chewing tobacco, snuff), chronic pancreatitis (requiring at least two years’ duration), acute pancreatitis (episode at least two years before onset), ionising radiation from alpha-emitting substances (with a latency of five years, the example being Thorotrast), (at least twenty years latency), (at least two years), and (with no specified minimum duration, only that the infection existed before clinical onset). The dictionary also defines as pneumonia, respiratory failure, cardiac arrest, circulatory failure or cessation of brain function, enabling a claim for death even if the immediate cause is one of those conditions, provided the pancreatic cancer contributed.

The primary group affected is veterans and members of the Australian Defence Force who have rendered relevant service (operational, peacekeeping, hazardous, British nuclear test defence, warlike or non-warlike service) and who develop or died from malignant neoplasm of the exocrine pancreas. Their dependants, widows or widowers who claim compensation or pension are also directly affected, because the SoP determines whether the disease is accepted as service-related. The instrument imposes a compliance burden on claimants to gather evidence of risk factors and their connection to service , often medical records spanning decades, proof of smoking history, weight documentation, laboratory results for hepatitis or diabetes, surgical records, occupational exposure logs (e.g. DDT spraying), and specialist reports confirming clinical onset dates. Practitioners , lawyers, advocates, and ex-service organisation representatives , must use the SoP to frame submissions; they need to know the precise timing requirements and the interaction with other SoPs. Decision-makers at the Department of Veterans' Affairs, the Veterans' Review Board, the Administrative Appeals Tribunal and the courts are bound to apply the SoP when assessing claims for pancreatic cancer. Medical advisers employed by the Department or retained by claimants must structure their opinions around the listed factors; opinions that rely on unlisted causes (e.g. genetic predisposition, other chemical exposures) will not satisfy the reasonable hypothesis standard unless they are linked to service in a way not captured by the SoP , but the RMA has declared the list exhaustive for the hypothesis standard. The instrument also affects other compensation systems by reference: the MRCA incorporates the same SoP for its members, so personnel with warlike or non-warlike service are subject to the same regime. The SoP may have spillover effects on common law claims under the Safety, Rehabilitation and Compensation Act 1988 for non-operational service, although that Act uses a different standard , the SoP is not binding there but may be used as persuasive evidence. The cost of compliance falls on individual claimants who must prove factors (which may require expensive expert reports or historical records) and on the public purse through legal aid, tribunal proceedings, and compensation payouts. The concentration of benefits on a small number of claimants with pancreatic cancer is matched by diffuse costs to taxpayers. The instrument may also affect the behaviour of serving personnel if they perceive the SoP as altering the risk-reward calculus for service in hazardous environments or for engaging in activities like smoking (but the direction of any behavioural change is unclear, as the SoP does not impose positive duties; it merely eases access to compensation).

The SoP imposes no duties on private persons; it is a legislative instrument that creates a framework for decision-makers. The RMA has a statutory duty under section 196B(2) VEA to determine SoPs based on sound medical-scientific evidence. That duty is procedural and the RMA has discretion over content, but once made the SoP is binding. Decision-makers have a duty to apply the SoP when determining whether a reasonable hypothesis exists. If a claimant has at least one factor in section 9 and that factor is related to relevant service, the decision-maker must find the reasonable hypothesis satisfied unless there is evidence that disproves the hypothesis beyond reasonable doubt. Conversely, if no factor exists, the decision-maker cannot find a reasonable hypothesis on the basis of that SoP alone , but external medical evidence might still raise a hypothesis if it falls outside the SoP's scope, although the authority of the SoP means such evidence would need to overcome the RMA’s declaration that the SoP is based on sound medical-scientific evidence; in practice, this is extremely difficult. Claimants have the right to have their claim assessed under the SoP and to be informed of the factors and temporal requirements. They also have the right to challenge a decision through internal review and tribunal/court proceedings. The SoP also creates a right to rely on chain cross-references under section 11: if a factor refers to an injury or disease covered by another SoP (e.g. diabetes or chronic pancreatitis), then the claimant can rely on that SoP to establish the factor. This means a claimant may only need to show a history of diabetes, not that the diabetes itself is service-related , but wait: section 11 says the factor refers to an injury or disease in respect of which a SoP has been determined. It then says "the factors in that Statement of Principles apply". This is ambiguous: the note signals that the SoP for the underlying condition will define whether that disease is service-related. So a claimant cannot simply say "I have diabetes"; if the diabetes factor is relied on, the decision-maker must apply the SoP for diabetes to determine whether that diabetes is itself related to service. In effect, the pancreatic cancer SoP incorporates the entire body of other SoPs by reference, increasing the complexity and the number of factors a claimant must prove. Practitioners should treat each factor as potentially triggering a separate SoP analysis. The right to rely on the SoP is thus circumscribed by the need to satisfy the chain. Finally, a key procedural right: the SoP applies to claims under sections that incorporate the reasonable hypothesis standard; for claims under the balance of probabilities standard (e.g. peacetime service under VEA), different rules apply even if the factors are the same.

This SoP contains no penalty provisions. It is not a criminal or civil penalty instrument. Enforcement occurs through the administrative review and litigation process. If a decision-maker incorrectly applies the SoP (for example, by denying a claim despite the existence of a factor related to service, or by incorrectly calculating pack-years), the claimant may seek review. The primary enforcement mechanism is the right to apply to the Veterans' Review Board and then to the Administrative Appeals Tribunal, and ultimately judicial review in the Federal Court. There is no monetary penalty for non-compliance by officials, but erroneous decisions can be set aside and remitted. For claimants or representatives who submit false or misleading information (e.g. fabricated smoking history or manufactured exposure records), the general criminal law applies: fraud and false statements in relation to Commonwealth entitlements carry penalties under the Criminal Code 1995, including imprisonment. The SoP itself does not create new offences. Additionally, the RMA enjoys immunity from suit in relation to the content of the SoP; it is a legislative instrument and can only be challenged for jurisdictional error or constitutional invalidity, not on its merits. The practical enforcement pressure is on decision-makers: they must correctly apply the factor definitions and timing rules. The SoP is silent on any audit or compliance function; the Department of Veterans' Affairs procedures would include internal quality assurance. The instrument's rigid factor list reduces enforcement discretion but also creates strict liability-type outcomes: if a claimant meets a factor, the hypothesis must be raised unless contradictory medical evidence undermines it. That shifts enforcement from rule-application to evidence-gathering. The cost of erroneous enforcement (a wrong denial) falls on the claimant, while a wrong acceptance imposes costs on taxpayers. There is no intrinsic incentive for decision-makers to favour one outcome over the other, although the government may have fiscal incentives to minimise payouts. The SoP does not address how disputes about the reliability of scientific evidence are resolved; the RMA’s view is determinative unless the claimant can produce compelling contradictory medical-scientific evidence, which is rare given the RMA’s expert panel. In practice, the SoP functions as a de facto evidentiary code.

This SoP operates within a broader statutory framework. It is made under subsection 196B(2) of the VEA, which authorises the RMA to determine SoPs for the purposes of subsections 120A(3) and 120B(3) of that Act. The standard of proof for operational service (section 120 VEA) requires that a reasonable hypothesis connecting the injury or disease to service must be raised unless disproved beyond reasonable doubt. Section 120A defers to the SoP: for claims involving operational service, the question whether a reasonable hypothesis exists is to be determined in accordance with the relevant SoP. This SoP thus overrides any other medical evidence that is not reflected in the factors; the hypothesis can only be raised via the listed factors. For non-operational service (e.g. peacetime peacetime service under VEA) the standard is balance of probabilities under section 120(4), and the SoP does not directly apply, but section 120B introduces a SoP regime for those claims as well , however, this SoP is expressly made under subsection 196B(2) (reasonable hypothesis) rather than subsection 196B(8) (balance of probabilities). It only applies to claims under section 120A (operational/peacekeeping/hazardous) and section 338 of the MRCA. The MRCA has its own standard of proof provisions: section 338 states that a determination of a claim is to be made to the reasonable satisfaction of the decision-maker, which is effectively the civil standard. The note in the instrument references both VEA and MRCA, but the SoP itself is made under the VEA and then applied to MRCA claims by regulation or practice. The instrument also interacts with other SoPs via section 11: if a factor (e.g., diabetes mellitus at factor 4) refers to an injury or disease that is the subject of another SoP, then the factors in that disease-specific SoP apply. This means a claimant who relies on diabetes must also satisfy the diabetes SoP (e.g., show that the diabetes is related to service). Similarly, chronic pancreatitis (factor 5), hepatitis B/C, etc., trigger their own SoPs. This creates a cascading requirement: the pancreatic cancer claim may fail unless the antecedent condition is itself service-connected. The interaction also works in the opposite direction: the pancreatic cancer SoP may be used as the antecedent SoP for other conditions. The dictionary definitions (e.g., "being overweight/obese") are drawn from medical standards that are also used in other contexts (e.g., workers' compensation, health insurance). The ICD-10-AM code referenced (C25 series) is a disease classification system used in hospitals, not a legal presumption. The instrument expressly excludes endocrine tumours, which would be covered by a different SoP. Finally, the SoP is subordinate to the VEA and MRCA; if its terms are inconsistent with a provision of those Acts, the Acts prevail. There is no direct interaction with state workers' compensation or tort law.

The instrument provides limited amendment history. It is titled "Statement of Principles concerning malignant neoplasm of the pancreas (Reasonable Hypothesis) (No. 103 of 2021)". It commences on 1 November 2021. It repeals the earlier SoP No. 73 of 2013, made under subsections 196B(2) and (8) of the VEA. That 2013 instrument covered both the reasonable hypothesis and balance of probabilities standards. The 2021 version appears to cover only the reasonable hypothesis standard (subsection 196B(2)), which suggests a separate instrument may exist for the balance of probabilities standard (subsection 196B(8)) , although the source text does not include that. The user's document includes no further amendment history. It does not list any amendments between 2013 and 2021. It shows that the RMA can and does periodically review and replace SoPs. The 2013 version was repealed; the 2021 version has not been amended since commencement. Practitioners should verify whether any further instruments have amended it after 2021 (the source text is dated 1 October 2021). The SoP also incorporates amendments to the VEA and MRCA via their definitions (e.g., "relevant service" may change if the Acts are amended). The instrument itself can be amended by the RMA without parliamentary approval, subject to disallowance. The lack of amendment history in the source means we cannot comment on whether the factors changed significantly from 2013. However, the repeal of a single instrument that previously covered both standards suggests a split in the 2021 version, possibly reflecting a stricter distinction between the two standards. The amendment history also affects reliance: if a claim is made after 1 November 2021, the 2021 SoP applies; if the claim was lodged before but not yet determined, the transitional provisions of the VEA or MRCA might apply. The instrument does not contain transitional provisions itself , presumably they are in the parent Acts.

The source text provides no information on litigation history. No cases, tribunal decisions or court judgments are cited or referenced. The SoP is a legislative instrument and is not itself the subject of litigation (except for judicial review challenges, which are rare). In the veterans' jurisdiction, litigation typically arises from decisions made under SoPs. Given the absence of cited cases, the deep dive must note that the instrument does not contain any case references. Practitioners should be aware that there may be Administrative Appeals Tribunal or Federal Court decisions interpreting the previous SoP (No. 73 of 2013) or the factors in the current SoP, but we cannot invent them. The source does not indicate that this SoP has been challenged. The "litigation history" section must rely solely on what is in the source; we cannot assume there are cases. We can observe that the SoP’s factor definitions (e.g., "being overweight or obese", "clinically onset") are likely to be contested in individual claims, but no specific litigation is recorded here. This limitation is important for the audience: any practitioner using this instrument should search for cases dealing with the predecessor SoP or analogous factors, because the same definitions may have been interpreted before. The instrument itself creates no presumption of correctness for any interpretation. The lack of an internal litigation record means the SoP stands alone as a technical medical-legal definition. The RMA is not a court and its determinations are not binding legal precedents , they are administrative findings. Therefore, the litigation history is essentially the history of claims under this and prior SoPs, which is external to the source. In fulfilling the instruction to use only what the source provides, we can note the absence and comment that the SoP's effect on litigation is prospective and will depend on how decision-makers and tribunals apply its specific temporal and quantitative requirements.

Several traps for the unwary practitioner arise from the precise wording of the SoP. First, the definition of malignant neoplasm of the pancreas is restricted to exocrine pancreas only. Endocrine tumours (e.g., pancreatic neuroendocrine tumours) are explicitly excluded, even though laypeople and some medical reports may refer to them as pancreatic cancer. A claimant with a neuroendocrine tumour will not succeed under this SoP; a different SoP (for endocrine neoplasms) would be needed. Second, the latency and cessation windows for smoking are strict. Factor 1 requires smoking to have started at least five years before clinical onset, and if the person stopped smoking, the onset must occur within 20 years of cessation. This means a veteran who smoked heavily thirty years ago but only developed pancreatic cancer forty years later cannot use this factor. Conversely, a current smoker has no cessation ceiling, but must have at least 10 pack-years. Third, the definition of being overweight or obese is deceptively broad: it includes waist circumference thresholds (94 cm male, 80 cm female). Many veterans who have a BMI under 25 (normal weight) may still have a waist circumference exceeding those limits and thus satisfy the factor. Medical records often do not record waist circumference, so claimants may need to prove historical measurements or rely on self-reporting. Fourth, factor 7 (DDT exposure) requires a cumulative 1,000 hours. This is a high threshold , equivalent to about 25 work weeks of full-time exposure. The activities listed are narrow; simply having been in a building where DDT was sprayed is not sufficient. A veteran must prove they engaged in a specific enumerated activity. Fifth, factor 8 (partial gastrectomy) requires the surgery to have been performed at least 20 years before clinical onset. This is a very long latency; many veterans who had gastrectomies for ulcers may not have medical records dating back 20+ years. Sixth, factor 9 (ionising radiation) is limited to internal deposition of alpha-emitting therapeutic or diagnostic substances. Typical radiotherapy using external beam or beta/gamma emitters does not count. Thorotrast is the only example given, and it was rarely used after the 1950s. This factor is effectively obsolete but included for completeness. Seventh, factor 13 (inability to obtain appropriate clinical management) applies only to material contribution or aggravation where the disease existed before or during service but did not arise out of service. This means a person whose cancer was already present before they enlisted might still get compensation if they can show that because of service they could not get proper treatment (e.g., posted to a remote area without oncology). That is a high bar. Eighth, the under section 11 means that relying on diabetes or pancreatitis as a factor forces the claimant to also prove those conditions are service-related under their own SoPs. This potentially doubles the evidentiary burden. Ninth, the instrument applies only to as defined; for non-warlike MRCA service, the standard is reasonable satisfaction, not reasonable hypothesis , yet the SoP is still applied because MRCA section 338 adopts SoPs. The distinction is critical. Tenth, the dictionary definition of includes cessation of brain function; this means that if a person with pancreatic cancer dies of cardiac arrest, the death is still considered due to the cancer for the purpose of the claim. But that only applies if the cancer contributed to the terminal event; mere timing is insufficient.

Compliance for claimants and their representatives requires systematic gathering of evidence for each factor that might apply. First, obtain a definitive diagnosis confirming exocrine pancreatic cancer (ICD-10-AM codes C25.0-C25.3, C25.7-C25.8) and an opinion on clinical onset , the date when symptoms first became apparent or when the diagnosis was made, whichever is earlier. This date is the temporal anchor for almost every factor. Second, create a factor map by listing the thirteen factors and checking medical and service history against each. Smoking history: calculate pack-years precisely; if smoking ceased, ensure onset within 20 years of cessation. Record the start date (must be at least 5 years before onset). For weight: obtain weight and height records to compute BMI, or waist measurements. If BMI fluctuated, document the periods of overweight/obesity to confirm at least 5 years within the 30 years before onset. Diabetes: check for a diagnosis at least 5 years before onset; glucose or HbA1c records may be needed. Pancreatitis: differentiate acute from chronic; both require a two-year latency. DDT exposure: gather service records showing posting to areas where DDT was used or occupational health records. The 1,000-hour cumulative requirement may be satisfied by repeated spraying or cleaning duties; keep a diary or log. Gastrectomy: locate surgical records, pathology reports, or statements from the veteran or treating doctors confirming a partial gastrectomy at least 20 years earlier. Ionising radiation: extremely rare; check for Thorotrast imaging or alpha-emitting diagnostic substances; unlikely in modern service. Cholelithiasis or cholecystectomy: look for diagnoses or surgical notes at least 2 years before onset. Hepatitis B or C: serology results before onset; if the infection is recent, the factor likely fails. Inability to obtain clinical management: requires evidence that the veteran was unable to receive appropriate treatment due to service circumstances (e.g., posted overseas, remote location). This will usually need a medical opinion and service records about treatment availability.

Once factors are identified, link each to relevant service. For example, smoking: establish that tobacco products were bought or consumed during operational deployments, or that the smoking habit began or increased due to service stressors (though the SoP does not require that the factor be caused by service, only that it exist and be related to service). Section 10(1) says the factor must be related to the relevant service rendered by the person. That is the crucial connection. If the veteran started smoking after service, then smoking may not be related to service. Similarly, diabetes may be related to service if it arose from a service-related condition (e.g., obesity from sedentary service). Decision-makers will expect a causal or temporal nexus. The dictionary defines "relevant service" narrowly; ensure the person rendered the exact type of service listed.